PIP5K1A and neoplasm: Our new finding identifies the N-terminal domain of the lipid kinase PIP5K1α is important to control the growth of PCa, thus may serve as an ideal drug target for designing new PIP5K1α inhibitor to suppress tumor growth by blocking PIP5K1α activity.